Press release
Respiratory Syncytial Virus Vaccines Market Trends and Forecast Report 2022 | By Players, Types, Applications and Regions
QY Research released a latest market research report on the global and United States Respiratory Syncytial Virus Vaccines market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region, by Type and by Application for the period 2017-2028.For United States market, this report focuses on the Respiratory Syncytial Virus Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For More Information About This Report, Please Enter:
https://us.qyresearch.com/reports/353901/respiratory-syncytial-virus-vaccines
Respiratory Syncytial Virus Vaccines Market Segment by Type
Palivizumab
RSVpreF PF06928316
RSVPreF3 OA (GSK3844766A)
mRNA-1345
Janssen RSV Vaccine
ResVax
Nirsevimab (MEDI8897)
MVA-BN RSV
Respiratory Syncytial Virus Vaccines Market Segment by Application
Hospital
Clinic
Research Institute
The report on the Respiratory Syncytial Virus Vaccines market covers the following region analysis:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
The report mentions the prominent market player consisting of:
Pfizer Inc.Pfizer Inc.
Sanofi
Merck Sharp & Dohme
GlaxoSmithKline
SOBI
Johnson & Johnson
Bavarian Nordic
Novavax
AstraZeneca
Moderna
Codagenix
Intravacc
Alphavax
The Goal of the Report
To study and analyze the global Respiratory Syncytial Virus Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Respiratory Syncytial Virus Vaccines market by identifying its various subsegments.
Focuses on the key global Respiratory Syncytial Virus Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Respiratory Syncytial Virus Vaccines with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Respiratory Syncytial Virus Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Target Audience
> Respiratory Syncytial Virus Vaccines companies
> Research organizations
> Government Organizations
> Research/Consultancy firms
Table of Contents
1 Study Coverage
1.1 Respiratory Syncytial Virus Vaccines Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million) Introduction
1.2 Global Respiratory Syncytial Virus Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Respiratory Syncytial Virus Vaccines Market Size for the Year 2017-2028
1.2.2 Global Respiratory Syncytial Virus Vaccines Market Size for the Year 2017-2028
1.3 Respiratory Syncytial Virus Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Respiratory Syncytial Virus Vaccines in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Respiratory Syncytial Virus Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Respiratory Syncytial Virus Vaccines Market Dynamics
1.4.1 Respiratory Syncytial Virus Vaccines Industry Trends
1.4.2 Respiratory Syncytial Virus Vaccines Market Drivers
1.4.3 Respiratory Syncytial Virus Vaccines Market Challenges
1.4.4 Respiratory Syncytial Virus Vaccines Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Respiratory Syncytial Virus Vaccines by Type
2.1 Respiratory Syncytial Virus Vaccines Market Segment by Type
2.1.1 Palivizumab
2.1.2 RSVpreF PF06928316
2.1.3 RSVPreF3 OA (GSK3844766A)
2.1.4 mRNA-1345
2.1.5 Janssen RSV Vaccine
2.1.6 ResVax
2.1.7 Nirsevimab (MEDI8897)
2.1.8 MVA-BN RSV
2.2 Global Respiratory Syncytial Virus Vaccines Market Size by Type (2017, 2022 & 2028)
2.3 Global Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2028)
2.4 United States Respiratory Syncytial Virus Vaccines Market Size by Type (2017, 2022 & 2028)
2.5 United States Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2028)
3 Respiratory Syncytial Virus Vaccines by Application
3.1 Respiratory Syncytial Virus Vaccines Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Research Institute
3.2 Global Respiratory Syncytial Virus Vaccines Market Size by Application (2017, 2022 & 2028)
3.3 Global Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2028)
3.4 United States Respiratory Syncytial Virus Vaccines Market Size by Application (2017, 2022 & 2028)
3.5 United States Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2028)
4 Global Respiratory Syncytial Virus Vaccines Competitor Landscape by Company
4.1 Global Respiratory Syncytial Virus Vaccines Market Size by Company
4.1.1 Top Global Respiratory Syncytial Virus Vaccines Companies Ranked by Revenue (2021)
4.1.2 Global Respiratory Syncytial Virus Vaccines Revenue by Player (2017-2022)
4.2 Global Respiratory Syncytial Virus Vaccines Concentration Ratio (CR)
4.2.1 Respiratory Syncytial Virus Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Respiratory Syncytial Virus Vaccines in 2021
4.2.3 Global Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Respiratory Syncytial Virus Vaccines Headquarters, Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million) Type
4.3.1 Global Respiratory Syncytial Virus Vaccines Headquarters and Area Served
4.3.2 Global Respiratory Syncytial Virus Vaccines Companies Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Respiratory Syncytial Virus Vaccines Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Respiratory Syncytial Virus Vaccines Market Size by Company
4.5.1 Top Respiratory Syncytial Virus Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Respiratory Syncytial Virus Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Respiratory Syncytial Virus Vaccines Market Size by Region
5.1 Global Respiratory Syncytial Virus Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2028)
5.2.1 Global Respiratory Syncytial Virus Vaccines Market Size by Region: 2017-2022
5.2.2 Global Respiratory Syncytial Virus Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Respiratory Syncytial Virus Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Respiratory Syncytial Virus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Respiratory Syncytial Virus Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Respiratory Syncytial Virus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Respiratory Syncytial Virus Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Respiratory Syncytial Virus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.4.6 Colombia
6.5 Middle East and Africa
6.5.1 Middle East and Africa Respiratory Syncytial Virus Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Respiratory Syncytial Virus Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer Inc.Pfizer Inc.
7.1.1 Pfizer Inc.Pfizer Inc. Company Details
7.1.2 Pfizer Inc.Pfizer Inc. Business Overview
7.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Introduction
7.1.4 Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.1.5 Pfizer Inc.Pfizer Inc. Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Respiratory Syncytial Virus Vaccines Introduction
7.2.4 Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Merck Sharp & Dohme
7.3.1 Merck Sharp & Dohme Company Details
7.3.2 Merck Sharp & Dohme Business Overview
7.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Introduction
7.3.4 Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.3.5 Merck Sharp & Dohme Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Details
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Introduction
7.4.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.4.5 GlaxoSmithKline Recent Development
7.5 SOBI
7.5.1 SOBI Company Details
7.5.2 SOBI Business Overview
7.5.3 SOBI Respiratory Syncytial Virus Vaccines Introduction
7.5.4 SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.5.5 SOBI Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Details
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Introduction
7.6.4 Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.6.5 Johnson & Johnson Recent Development
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Company Details
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Introduction
7.7.4 Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.7.5 Bavarian Nordic Recent Development
7.8 Novavax
7.8.1 Novavax Company Details
7.8.2 Novavax Business Overview
7.8.3 Novavax Respiratory Syncytial Virus Vaccines Introduction
7.8.4 Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.8.5 Novavax Recent Development
7.9 AstraZeneca
7.9.1 AstraZeneca Company Details
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Introduction
7.9.4 AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.9.5 AstraZeneca Recent Development
7.10 Moderna
7.10.1 Moderna Company Details
7.10.2 Moderna Business Overview
7.10.3 Moderna Respiratory Syncytial Virus Vaccines Introduction
7.10.4 Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.10.5 Moderna Recent Development
7.11 Codagenix
7.11.1 Codagenix Company Details
7.11.2 Codagenix Business Overview
7.11.3 Codagenix Respiratory Syncytial Virus Vaccines Introduction
7.11.4 Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.11.5 Codagenix Recent Development
7.12 Intravacc
7.12.1 Intravacc Company Details
7.12.2 Intravacc Business Overview
7.12.3 Intravacc Respiratory Syncytial Virus Vaccines Introduction
7.12.4 Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.12.5 Intravacc Recent Development
7.13 Alphavax
7.13.1 Alphavax Company Details
7.13.2 Alphavax Business Overview
7.13.3 Alphavax Respiratory Syncytial Virus Vaccines Introduction
7.13.4 Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
7.13.5 Alphavax Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
Access full Report Description, Table of Figure, Chart, Free sample, etc. please click
https://us.qyresearch.com/reports/353901/respiratory-syncytial-virus-vaccines
Any doubts and questions will be welcome.
Customization of the Report:
This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
About Us:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QY Research released a latest market research report on the global and United States Respiratory Syncytial Virus Vaccines market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region, by Type and by Application for the period 2017-2028.
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Syncytial Virus Vaccines Market Trends and Forecast Report 2022 | By Players, Types, Applications and Regions here
News-ID: 2626070 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
